Skip to Main Content
Skip Nav Destination

The vaccine against yellow fever is one of the safest and most effective ever developed. With an outstanding record in humans, has this live attenuated vaccine been overlooked as a promising vector for the development of vaccines against pathogens outside its own genus? Recent studies, including a report by Tao et al. on page 201 of this issue, have sparked renewed interest.

You do not currently have access to this content.
Don't already have an account? Register

or Create an Account

Close Modal
Close Modal